Skip to main content
Subscribe
  • Login
  • My Account
  • Logout
  • Register For Free
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HLTH 2024
    • Sponsored Content: Vital Signs Blog
  • Opinion
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • 40 Under 40
    • Best Places to Work in Healthcare
    • Healthcare Marketing Impact Awards
    • Innovators Awards
    • Diversity Leaders
    • Leading Women
    • Best in Business Awards
    • The 2030 Playbook Conference
    • Innovations in Patient Experience
    • Leading Women Conference & Awards Luncheon
    • Leadership Summit
    • Workforce Summit
    • Best Places to Work Awards Gala
    • Diversity Leaders Gala
    • - Looking Ahead to 2025
    • - Financial Growth
    • - Hospital of the Future
    • - Value Based Care
    • - Looking Ahead to 2026
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Skilled Nursing Facilities
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
    • Sponsored Content
MENU
Breadcrumb
  1. Home
  2. Supply Chain
June 06, 2023 05:00 AM

HRSA silence on 340B drug discount status worries hospitals

Alex Kacik
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Drug price transparency
    MH Illustration/Unsplash

    Some hospital outpatient clinics may lose their 340B drug discount status despite pleas by trade groups to the federal government.

    On May 11, the Health Resources and Services Administration removed guidance from its website, issued in June 2020 during the COVID-19 pandemic, that allowed 340B-eligible hospitals to prescribe discounted drugs for patients seen at off-site clinics before those clinics were registered with the Office of Pharmacy Affairs Information System and were listed on a Medicare cost report. Hospitals expected the June 2020 guidance to be made permanent rather than tied to the COVID-19 public health emergency, which ended May 11.

    The 340B drug discount program gives some 2,600 eligible hospitals that treat low-income and uninsured patients drug discounts as steep as 50%. If guidance is rescinded, hospitals must wait up to two years after an off-site clinic opens to access the discounts.

    A change could result in the loss of tens of millions of dollars in expected annual savings for some hospitals with broad outpatient networks, said Emily Cook, a partner at law firm McDermott Will & Emery who advises hospitals and health systems.

    “For many of hospitals, 340B is how they are keeping their doors open,” she said. “There would be an impact for all [340B] covered hospitals because if they were to establish a new [off-site] location, they would have a delay of nine to 21 months after it opens to access 340B drugs.”

    Cook said she is working with hospital clients on a potential lawsuit if the guidance changes. In a May 11 letter to HRSA, America’s Essential Hospitals CEO Dr. Bruce Siegel wrote that the trade group, which represents 340B-elgibile hospitals, has “serious concerns that the inadequate notice and lack of explanation for this change are unreasonable and inconsistent with requirements under federal administrative law.”

    HRSA, a branch of the Health and Human Services Department, did not immediately respond to a request for comment.

    HRSA should provide some clarity because it's unclear whether the agency changed its guidance, said Maureen Testoni, CEO of 340B Health, a trade group that represents 340B-eligible hospitals. 

    In America’s Essential Hospitals letter to HRSA, Siegel referenced a member hospital that invested $16 million into specialty clinics, one of which was an off-site facility that treats HIV and hepatitis C patients. If the June 2020 guidance has been reversed, the hospital would have to wait until it files its 2023 Medicare cost report to register those clinics, resulting in an estimated $2.5 million financial hit per month because it wouldn’t be able to use and prescribe 340B drugs in the interim, Siegel said, noting the hospital is already operating in the red.

    That same hospital is building a clinic set to open later this year, which would have to wait 18 months to use 340B drugs, Siegel said.

    The uncertainty is the latest hurdle for the 340B program, which was designed to allow hospitals to reinvest the savings in programs for the poor or to pass the discounts to patients and insurers. Critics of the program contend that some hospitals exploit the drug discounts to generate profits, resulting in a number of lawsuits involving drugmakers, providers and state and federal officials, some of which are pending. 

    Some hospitals may lose their 340B status as thousands of Medicaid beneficiaries lose coverage as states redetermine their eligibility. Through the COVID-19 pandemic, the federal government allowed people to remain on Medicaid even when their income should have excluded them from the program. The 340B statutes only allow hospitals to buy discounted drugs if they treat a certain percentage of Medicaid and low-income Medicare patients, as measured by the disproportionate share hospital adjustment percentage. 

    Meanwhile, about two dozen drug manufacturers have limited 340B discounts in recent months on drugs dispensed through contract pharmacies. The Third Circuit Court of Appeals in January ruled in favor of three drug companies that imposed limits on 340B drug discounts provided to hospitals via contract pharmacies.

    Related Articles
    Influential advisory panel asks CMS to reject $1.65 billion in cuts to 340B
    Drugmakers restrict 340B sales after appellate court ruling
    Health systems nervous as Medicaid redeterminations threaten shaky bottom lines
    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Dollar sign money
    KKR takes strategic stake in medical supplier Henry Schein
    UPS
    How healthcare became UPS’ $20B lifeline
    Most Popular
    1
    Downside risk, upside payment highlight new CMS innovation agenda
    2
    UnitedHealth Group CEO Andrew Witty steps down
    3
    AI health risk assessments aim to boost Medicare Advantage pay
    4
    Why healthcare staffing companies are buying competitors
    5
    Docs set for Medicare pay hike under House GOP bill
    Sponsored Content
    Daily Dose Newsletter: Sign up to receive a late afternoon weekday roundup of that day’s breaking news and developments in healthcare.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2025. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HLTH 2024
      • Sponsored Content: Vital Signs Blog
    • Opinion
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • 40 Under 40
        • Best Places to Work in Healthcare
        • Healthcare Marketing Impact Awards
        • Innovators Awards
        • Diversity Leaders
        • Leading Women
        • Best in Business Awards
      • Conferences
        • The 2030 Playbook Conference
        • Innovations in Patient Experience
        • Leading Women Conference & Awards Luncheon
        • Leadership Summit
        • Workforce Summit
      • Galas
        • Best Places to Work Awards Gala
        • Diversity Leaders Gala
      • Virtual Briefings
        • - Looking Ahead to 2025
        • - Financial Growth
        • - Hospital of the Future
        • - Value Based Care
        • - Looking Ahead to 2026
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Skilled Nursing Facilities
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing
      • Sponsored Content